Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.

Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M.

Biochem Biophys Res Commun. 2011 Oct 28;414(3):635-40. doi: 10.1016/j.bbrc.2011.09.147. Epub 2011 Oct 6.

PMID:
22001930
2.

The ratio of unsaturated fatty acids in biosurfactants affects the efficiency of gene transfection.

Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M.

Int J Pharm. 2010 Oct 15;398(1-2):225-30. doi: 10.1016/j.ijpharm.2010.07.042. Epub 2010 Jul 30.

PMID:
20674726
3.

Characterization of biosurfactant-containing liposomes and their efficiency for gene transfection.

Ueno Y, Hirashima N, Inoh Y, Furuno T, Nakanishi M.

Biol Pharm Bull. 2007 Jan;30(1):169-72.

4.

NBD-conjugated biosurfactant (MEL-A) shows a new pathway for transfection.

Ueno Y, Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M.

J Control Release. 2007 Nov 20;123(3):247-53. Epub 2007 Aug 19.

PMID:
17884224
5.

Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion.

Inoh Y, Kitamoto D, Hirashima N, Nakanishi M.

J Control Release. 2004 Feb 10;94(2-3):423-31.

PMID:
14744492
6.

Synergistic effect of a biosurfactant and protamine on gene transfection efficiency.

Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M.

Eur J Pharm Sci. 2013 Apr 11;49(1):1-9. doi: 10.1016/j.ejps.2013.02.001. Epub 2013 Feb 16.

PMID:
23422688
7.

The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.

Tagami T, Barichello JM, Kikuchi H, Ishida T, Kiwada H.

Int J Pharm. 2007 Mar 21;333(1-2):62-9. Epub 2006 Oct 10.

PMID:
17097247
8.

Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.

Kim HK, Davaa E, Myung CS, Park JS.

Int J Pharm. 2010 Jun 15;392(1-2):141-7. doi: 10.1016/j.ijpharm.2010.03.047. Epub 2010 Mar 25.

PMID:
20347025
9.

Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.

Chien PY, Wang J, Carbonaro D, Lei S, Miller B, Sheikh S, Ali SM, Ahmad MU, Ahmad I.

Cancer Gene Ther. 2005 Mar;12(3):321-8.

PMID:
15578064
10.

Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome.

Igarashi S, Hattori Y, Maitani Y.

J Control Release. 2006 May 30;112(3):362-8. Epub 2006 Apr 19.

PMID:
16624437
11.

Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.

Beh CW, Seow WY, Wang Y, Zhang Y, Ong ZY, Ee PL, Yang YY.

Biomacromolecules. 2009 Jan 12;10(1):41-8. doi: 10.1021/bm801109g.

PMID:
19072631
12.

Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes.

Inoh Y, Kitamoto D, Hirashima N, Nakanishi M.

Biochem Biophys Res Commun. 2001 Nov 23;289(1):57-61.

PMID:
11708776
13.

siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.

Cardoso AL, Simões S, de Almeida LP, Pelisek J, Culmsee C, Wagner E, Pedroso de Lima MC.

J Gene Med. 2007 Mar;9(3):170-83.

PMID:
17351968
14.

Liposome vector containing biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene delivery system.

Maitani Y, Yano S, Hattori Y, Furuhata M, Hayashi K.

J Liposome Res. 2006;16(4):359-72.

PMID:
17162578
15.

Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.

Tagalakis AD, He L, Saraiva L, Gustafsson KT, Hart SL.

Biomaterials. 2011 Sep;32(26):6302-15. doi: 10.1016/j.biomaterials.2011.05.022. Epub 2011 May 31.

PMID:
21624650
16.

Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

Spagnou S, Miller AD, Keller M.

Biochemistry. 2004 Oct 26;43(42):13348-56.

PMID:
15491141
17.

Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.

Malamas AS, Gujrati M, Kummitha CM, Xu R, Lu ZR.

J Control Release. 2013 Nov 10;171(3):296-307. doi: 10.1016/j.jconrel.2013.06.019. Epub 2013 Jun 21.

18.

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.

Sonoke S, Ueda T, Fujiwara K, Sato Y, Takagaki K, Hirabayashi K, Ohgi T, Yano J.

Cancer Res. 2008 Nov 1;68(21):8843-51. doi: 10.1158/0008-5472.CAN-08-0127.

19.

Cellular delivery of siRNA mediated by fusion-active virosomes.

Huckriede A, De Jonge J, Holtrop M, Wilschut J.

J Liposome Res. 2007;17(1):39-47.

PMID:
17454402
20.

Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.

Yano J, Hirabayashi K, Nakagawa S, Yamaguchi T, Nogawa M, Kashimori I, Naito H, Kitagawa H, Ishiyama K, Ohgi T, Irimura T.

Clin Cancer Res. 2004 Nov 15;10(22):7721-6.

Items per page

Supplemental Content

Write to the Help Desk